Microribonucleic acids and vascular restenosis

Saudi Medical Journal

Volumn 35, Issue 8, 2014, Pages 796-801

  Fan, Zhi Xing ^a   Yang, Jian ^a  

^a CHINA THREE GORGES UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 132; MICRORNA 133; MICRORNA 143; MICRORNA 145; MICRORNA 146A; MICRORNA 15B; MICRORNA 195; MICRORNA 21; MICRORNA 221; MICRORNA 222; MICRORNA 23A; MICRORNA 24-2; MICRORNA 26A; MICRORNA 27A; MICRORNA 503; MICRORNA 638; MICRORNA 663; PLATELET DERIVED GROWTH FACTOR; RNA POLYMERASE II; UNCLASSIFIED DRUG;

ANGIOPLASTY; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; ENDOTHELIAL DYSFUNCTION; GENE THERAPY; GENETIC TRANSCRIPTION; HUMAN; PHENOTYPE; RESTENOSIS; RNA TRANSLATION; THROMBOCYTE AGGREGATION; THROMBOSIS; VASCULAR RESTENOSIS; VASCULAR SMOOTH MUSCLE; BLOOD VESSEL; PATHOPHYSIOLOGY; PHYSIOLOGY; STENOSIS, OCCLUSION AND OBSTRUCTION;

BLOOD VESSELS; CONSTRICTION, PATHOLOGIC; HUMANS; MICRORNAS;

EID: 84925964949     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Gruentzing AR, Senning A, Siegenthaler WE. Nonoperative dilatation of coronary artery stenosis,percutaneous transluminal coronary angioplasty. N Eng J Med 1979; 301: 61-68.
2. Garza L, Audeyw YW, Saucedo JF. Can we prevent in-stent restenosis. Curr Opin Cardiol 2002; 17: 518-525.
3. Suzuki HI, Miyazono K. Emerging complexity of micro RNA generation cascades. J Biochem 2011; 149: 15-25.
4. Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J, et al. The nuclear RNase III drosha initiates micro RNA processing. Nature 2003; 425: 415-419.
5. Newman MA, Hammond SM. Emerging paradigms of regulated micro RNA processing. Genes Dev 2010; 24: 1086-1092.
6. Small EM, Olson EN. Pervasive roles of micro RNAs in cardiovascular biology. Nature 2011; 469: 336-342.
7. Song Z, Li G. Role of specific micro RNAs in regulation of vascular smooth muscle cell differentiation and the response to injury. J Cardiovasc Transl Res 2011; 3: 246-250.
8. Zernecke A. Micro RNAs in the regulation of immune cell functions-implications for atherosclerotic vascular disease. J Thromb Haemost 2012; 107: 626-633.
9. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M, et al. mi R-15 and mi R-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A 2005; 102: 13944-13949.
10. Esau C, Davis S, Murray SF, Yu XX, Pandey SK, Pear M, et al. mi R-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metabolism 2006; 3: 87-98.
11. Calin GA, Cimmino A, Fabbri M, Ferracin M, Wojcik SE, Shimizu M, et al. Mi R-15a and mi R-16-1 cluster functions in human leukemia. Proc Natl Acad Sci U S A 2008; 105: 5166-5171.
12. O'Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D. Micro RNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci U S A 2007; 104: 1604-1609.
13. Mehran R, Mintz GS, Hong MK, Tio FO, Bramwell O, Brahimi A, et al. Validation of the in vivo intravascular ultrasound measurement of in-stent neointimal hyperplasia volumes. J Am Coll Cardol 1998; 32: 794-799.
14. Poon M, Bsdimon JJ, Fuster V. Overcoming restenosis with sirolimus: from alphabet soup to clinical reality. Lancet 2002; 359: 619-922.
15. Braun-Dullaeus RC, Mann MJ, Dzau VJ. Cell cycle progression: new therapeutic target for vascular proliferative disease. Circulation 1998; 98: 82-89.
16. Owens GK. Regulation of differentiation of vascular smooth muscle cells. Physiol Rev 1995; 75: 487-517.
17. Albinsson S, Sward K. Targeting smooth muscle micro RNAs for therapeutic benefit in vascular disease. Pharmacol Res 2013; 75: 28-36.
18. Elia L, Quintavalle M, Zhang J, Contu R, Cossu L, Latronico MV, et al. The knockout of mi R-143 and-145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease. Cell Death Differ 2009; 16: 1590-1598.
19. Takahashi K, Okita K, Nakagawa M, Yamanaka S. Induction of pluripotent stem cells from fibroblast cultures. Nat Protoc 2007; 2: 3081-3089.
20. Cheng Y, Liu X, Yang J, Lin Y, Xu DZ, Lu Q, et al. Micro RNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ Res 2009; 105: 158-166.
21. Chen JF, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM, et al. The role of micro RNA-1 and micro RNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 2006; 38: 228-233.
22. Cordes KR, Sheehy NT, White MP, Berry EC, Morton SU, Muth AN, et al. mi R-145 and mi R-143 regulate smooth muscle cell fate and plasticity. Nature 2009; 460: 705-710.
23. Quintavalle M, Elia L, Condorelli G, Courtneidge SA. Micro RNA control of podosome formation in vascular smooth muscle cells in vivo and in vitro. J Cell Biol 2010; 189: 13-22.
24. Heldin CH, Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 1999; 79: 1283-1316.
25. Boettger T, Beetz N, Kostin S, Schneider J, Kruger M. Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. J Clin Invest 2009; 199: 2634-2647.
26. Wang YS, Wang HY, Liao YC, Tsai PC, Chen KC, Cheng HY, et al. Micro RNA-195 regulates vascular smooth muscle cell phenotype and prevents neointimal formation. Cardiovasc Res 2012; 95: 517-526.
27. Hartmann D, Thum T. Micro RNAs and vascular (dys) function. Vascul Pharmacol 2011; 55: 92-105.
28. Yu ML, Wang JF, Wang GK, You XH, Zhao XX, Jing Q, et al. Vascular smooth muscle cell proliferation is influenced by let-7d micro RNA and its interaction with KRAS. Circ J 2011; 75: 703-709.
29. Merlet E, Atassi F, Motiani RK, Mougenot N, Jacquet A, Nadaud S, et al. mi R-424/322 regulates vascular smooth muscle cell phenotype and neointimal formation in the rat. Cardiovasc Res 2013; 98: 458-468.
30. Chen J, Yin H, Jiang Y, Radhakrishnan SK, Huang ZP, Li J, et al. Induction of micro RNA-1 by myocardin in smooth muscle cells inhibits cell proliferation. Arterioscler Thromb Vasc Biol 2011; 31: 368-375.
31. Torella D, Iaconetti C, Catalucci D, Ellison GM, Leone A, Waring CD, et al. Micro RNA-133 controls vascular smooth muscle cell phenotypic switch in vitro and vascular remodeling in vivo. Circulation Research 2011; 109: 880-893.
32. Wang J, Yan CH, Li Y, Xu K,Tian XX, Peng CF, et al.Micro RNA-31 controls phenotypic modulation of human vascular smooth muscle cells by regulating its target gene cellular repressor of E1A-stimulated genes. Exp Cell Res 2013; 319: 1165-1175.
33. Choe N, Kwon JS, Kim JR, Eoma GH,Kim Yk, Namc KI, et al. The micro RNA mi R-132 targets Lrrfip1 to block vascular smooth muscle cell proliferation and neointimal hyperplasia. Atherosclerosis 2013; 229: 348-355.
34. Davis BN, Hilyard AC, Nguyen PH, Lagna G, Hata A. Induction of micro RNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotype. J Biol Chem 2009; 284: 3728-3738.
35. Liu X, Cheng Y, Zhang S, Lin Y, Yang J, Zhang C. A necessary role of mi R-221 and mi R-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ Res 2009; 104: 476-487.
36. Liu X, Cheng Y, Yang J, Xu L, Zhang C. Cell-specific effects of mi R-221/222 in vessels: molecular mechanism and therapeutic application. J Mol Cell Cardiol 2012; 52: 245-255.
37. Davis BN, Hilyard AC, Nguyen PH, Lagna G, Hata A. Induction of micro RNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotype. J Biol Chem 2009; 284: 3728-3738.
38. Ji R, Liu X, Yang J. Micro RNA expression signature and antisense-mediated depletion reveal an essential role of micro RNA in vascular neointimal lesion formation. Circ Res 2007; 100: 1579-1567.
39. Sarkar J, Gou D, Turaka P, Viktorova E, Ramchandran R. Micro RNA-21 plays a role in hypoxia-mediated pulmonary artery smooth muscle cell proliferation and migration. Am J Physiol Lung Cell Mol Physiol 2010; 299: L861-L871.
40. Sun SG, Zheng B, Han M, Fang XM, Li HX, Miao SB, et al. mi R-146a and kruppel-like factor 4 form a feedback loop to participate in vascular smooth muscle cell proliferation. EMBO Rep 2011; 12: 56-62.
41. Ji R, Cheng Y, Yue J, Yang J, Liu X, Chen H, et al. Micro RNA expression signature and antisense-mediated depletion reveal an essential role of Micro RNA in vascular neointimal lesion formation. Circ Res 2007; 100: 1579-1588.
42. Dong S, Xiong W, Yuan J, Li J, Liu J, Xu X. Mi RNA-146a regulates the maturation and differentiation of vascular smooth muscle cells by targeting NF-m B expression. Mol Med Rep 2013; 8: 407-412.
43. Chan MC, Hilyard AC,Wu C, Davis BN, Hill NS, Lal A, et al. Molecular basis for antagonism between PDGF and the TGFbeta family of signalling pathways by control of mi R-24 expression. EMBO J 2010; 29: 559-573.
44. Leeper NJ, Raiesdana A, Kojima Y, Chu HJ, Azuma J. micro RNA-26a is a novel regulator of vascular smooth muscle cell function. J Cell Physiol 2011; 226: 1035-1043.
45. Kee HJ, Park S, Kwon JS, Choe N, Ahn Y, Kook H, et al. B cell translocation gene, a direct target of mi R-142-5p, inhibits vascular smooth muscle cell proliferation by down-regulating cell cycle progression. FEBS Lett 2013; 587: 2385-2392.
46. Kim S, Kang H. mi R-15b induced by platelet-derived growth factor signaling is required for vascular smooth muscle cell proliferation. BMB Rep 2013; 46: 550-554.
47. Li P, Liu Y, Yi B, Wang G, You X, Zhao X, et al. Micro RNA-638 is highly expressed in human vascular smooth muscle cells and inhibits PDGF-BB-induced cell proliferation and migration through targeting orphan nuclear receptor NOR1. Cardiovasc Res 2013; 99: 185-193.
48. Li P, Zhu N, Yi B, Wang N, Chen M, You X, et al. Micro RNA-663 regulates human vascular smooth muscle cell phenotypic switch and vascular neointimal formation. Circ Res 2013; 113: 1117-1127.
49. Solingen VC, Seghers L, Bijkerk R, Duijs JM, Roeten MK, Baelde HJ, et al. Antagomir mediated silencing of endothelial cell specific micro RNA-126 impairs ischemia induced angiogenesis. J Cell Mol Med 2009; 13: 1577-1585.
50. Krützfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, et al. Silencing of micro RNAs in vivo with 'antagomirs'. Nature 2005; 438: 685-689.
51. Li J, Bai H, Zhu Y, Wang XY, Wang F. Antagomir dependent micro RNA-205 reduction enhances adhesion ability of human corneal epithelial keratinocytes. Chin Med Sci J 2010; 25: 65-70.
52. Ma L, Reinhardt F, Pan E, Soutschek J, Bhat B. Therapeutic silencing of mi R-10b inhibits metastasis in a mouse mammary tumor model. Nat Biotechnol 2010; 28: 341-347.
53. Jin CY, Zhao YB, Yu L, Xu SJ, Fu GS. Micro RNA-21 mediates the rapamycin-induced suppression of endothelial proliferation and migration. FEBS Lett 2013; 587: 378-385.
54. Wahid F, Shehzad A, Khan T, Kim YY. Micro RNAs: synthesis, mechanism, function, and recent clinical trials. Biochim Biophys Acta 2010; 1803: 1231-1243.